Moreover, co-treatment with NF-κB inhibitor, PAO (0.1 μM) and (E)-4-(3-(3,5-dimethoxyphenyl)allyl)-2-methoxyphenol (10 μg/ml) inhibited colon cancer cell growth more significantly. The gene discussed is NFKB1; the disease is malignant colon neoplasm.